Cargando…

Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells

Angiotensin (Ang) II, the main effector peptide of the renin-angiotensin system, has been implicated in multiple aspects of cancer progression such as proliferation, migration, invasion, angiogenesis and metastasis. Ang-(1-7), is a biologically active heptapeptide, generated predominantly from AngII...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cambados, Nadia, Walther, Thomas, Nahmod, Karen, Tocci, Johanna M., Rubinstein, Natalia, Böhme, Ilka, Simian, Marina, Sampayo, Rocío, Del Valle Suberbordes, Melisa, Kordon, Edith C., Schere-Levy, Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687620/ https://www.ncbi.nlm.nih.gov/pubmed/29179450 http://dx.doi.org/10.18632/oncotarget.19290

Ejemplares similares

Treatment with Angiotensin-(1-7) Prevents Development of Oral Papilloma Induced in K-ras Transgenic Mice
por: Schere-Levy, Carolina, et al.
Publicado: (2022)

RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes
por: Recouvreux, María Sol, et al.
Publicado: (2015)

ANGIOTENSIN AND RENIN IN RAT AND DOG BRAIN
por: Fischer-Ferraro, Catalina, et al.
Publicado: (1971)

Further intracellular proteins and signaling pathways regulated by angiotensin-(1–7) in human endothelial cells
por: Meinert, Christian, et al.
Publicado: (2016)

Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling
por: Quaglino, Ana, et al.
Publicado: (2007)

The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle Cells
por: Villalobos, Laura A., et al.
Publicado: (2016)

Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II
por: Guo, Xiaohua, et al.
Publicado: (2014)

Central angiotensin 1–7 triggers brown fat thermogenesis
por: Evangelista, F. S., et al.
Publicado: (2023)

Angiotensin II during Experimentally Simulated Central Hypovolemia
por: Jensen, Theo Walther, et al.
Publicado: (2016)

Angiotensin-(1-7), Angiotensin-Converting Enzyme 2, and New Components of the Renin Angiotensin System
por: Trask, Aaron J., et al.
Publicado: (2009)

Angiotensin-(3–4) normalizes the elevated arterial blood pressure and abnormal Na(+)/energy handling associated with chronic undernutrition by counteracting the effects mediated by type 1 angiotensin II receptors
por: Pereira-Acácio, Amaury, et al.
Publicado: (2022)

Newer Insights into the Biochemical Physiology of the Renin–Angiotensin System: Role of Angiotensin-(1-7), Angiotensin Converting Enzyme 2, and Angiotensin-(1-12)
por: Ferrario, Carlos M., et al.
Publicado: (2009)

The BA-BCS 2021: An Initial “Trial” for Integrating Basic Science and Medical Progress on Breast Cancer in a Latin-American Country
por: Kordon, Edith, et al.
Publicado: (2021)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
por: Volpe, Massimo, et al.
Publicado: (2012)

New angiotensins
por: Varagic, Jasmina, et al.
Publicado: (2008)

Neuronal Angiotensin
por: Allen, A.M., et al.
Publicado: (2009)

Other Angiotensins
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension
por: van Sloten, Thomas T, et al.
Publicado: (2022)

Angiotensin Receptor Antagonists to Prevent Sudden Death in Heart Failure: Does the Dose Matter?
por: Francia, Pietro, et al.
Publicado: (2014)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

RENAL HYPERTENSION IN RATS IMMUNIZED AGAINST ANGIOTENSIN I AND ANGIOTENSIN II
por: Oates, Helen F., et al.
Publicado: (1974)

Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
por: Clark, Michelle A., et al.
Publicado: (2013)

Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system
por: Lambert, Daniel W., et al.
Publicado: (2008)

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers()
por: Douillard, Marie, et al.
Publicado: (2023)

Mechanical Stress Triggers Cardiomyocyte Autophagy through Angiotensin II Type 1 Receptor-Mediated p38MAP Kinase Independently of Angiotensin II
por: Lin, Li, et al.
Publicado: (2014)

Aberrant RET expression affects normal mammary gland post-lactation transition, enhancing cancer potential
por: Vallone, Sabrina A., et al.
Publicado: (2022)

Is angiotensin-(3–4) (Val-Tyr), the shortest angiotensin II-derived peptide, opening new vistas on the renin–angiotensin system?
por: Dias, Juliana, et al.
Publicado: (2017)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease
por: Larouche‐Lebel, Éva, et al.
Publicado: (2020)

Effect of angiotensin receptor blockers and angiotensin‐converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease
por: Huh, Terry, et al.
Publicado: (2020)

Angiotensin II Type 1 Receptor Antibodies Trigger Inflammation in Renal Transplantation
por: Philippe, Aurelie
Publicado: (2019)

Phosphatidylethanolamine aggravates Angiotensin II-induced atrial fibrosis by triggering ferroptosis in mice
por: Huang, Fangze, et al.
Publicado: (2023)

The Angiotensin-Melatonin Axis
por: Campos, Luciana A., et al.
Publicado: (2013)

Angiotensin in Critical Care
por: Hall, Anna, et al.
Publicado: (2018)

Angiotensin II Peptides
por: Izumi, Yasukatsu, et al.
Publicado: (2013)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Receptors | Angiotensin Receptors
por: Pardhi, Triveni R., et al.
Publicado: (2021)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Moretti, Myla E., et al.
Publicado: (2012)

Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
por: Ajmal, Adnan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_of1u3bo53oi64ep1vtjknqgfnl